Obsessive Compulsive Disorder Drugs Market is anticipated to grow at a significant CAGR during the forecast period. The major factors that are propelling market growth include increasing R&D investment and a rise in clinical trials by market players, which are expected to fuel the market growth during the forecast period. Obsessive-compulsive disorder (OCD) refers to an anxiety disorder that is characterized by unreasonable and uncontrollable thoughts and fears leading an individual to perform repetitive behaviours. Obsessive-compulsive disorder is a disorder known to compel a person to get stuck on a particular thought or fear. The developments in the treatment, therapies and novel treatment, and advancements in the anti-anxiety, antipsychotic and antidepressant drugs is expected to provide various other opportunities in the OCD drugs market.
The global obsessive compulsive disorder drugs market analysis includes some of the key market players such as Abbott Laboratories, Eli Lilly, and Company, Viatria Inc., H. Lundbeck A/S, Pfizer Inc., among others. In order to maintain a strong position in the market, the market players are adopting various strategic moves, such as product launches, partnerships, collaborations, and mergers and acquisitions. For instance, in August 2021, Alembic Pharmaceuticals declared that it has received final approval from the USFDA for its Abbreviated New Drug Application (ANDA) for Clomipramine Hydrochloride Capsules. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Anafranil Capsules of SpecGX LLC. Clomipramine Hydrochloride Capsules are indicated for the treatment of obsessions and compulsions in patients with obsessive-compulsive disorder (OCD). Alembic has a cumulative total of 149 ANDA approvals from USFDA.
To Request a Sample of our Report on Obsessive Compulsive Disorder Drugs Market: https://www.omrglobal.com/request-sample/obsessive-compulsive-disorder-drugs-market
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
- Segment Covered
- Regions Covered- Globally
Competitive Landscape: Abbott Laboratories, Eli Lilly, and Company, Viatria Inc., H. Lundbeck A/S, Pfizer Inc., among others.
Obsessive Compulsive Disorder Drugs Market Report Segmentation
By Product
- SSRI
- TCA
- Others
A full Report of Obsessive Compulsive Disorder Drugs Market is Available @ https://www.omrglobal.com/industry-reports/obsessive-compulsive-disorder-drugs-market
Obsessive Compulsive Disorder Drugs Market by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/obsessive-compulsive-disorder-drugs-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
